Trials / Unknown
UnknownNCT03642340
A Post-marketing Surveillance to Assess Safety and Efficacy of Besivo
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- IlDong Pharmaceutical Co Ltd · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study is a post-marketing surveillance of Besivo in participants with chronic hepatitis B.
Detailed description
This post-marketing surveillance required by Korea MFDS regulation. The objectives of this study are to monitor adverse events and effectiveness of Besivo.
Conditions
Timeline
- Start date
- 2017-05-15
- Primary completion
- 2023-05-14
- Completion
- 2023-08-15
- First posted
- 2018-08-22
- Last updated
- 2018-08-31
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03642340. Inclusion in this directory is not an endorsement.